Mizuho raised the firm’s price target on Herbalife (HLF) to $9 from $8 and keeps a Neutral rating on the shares. The company’s Q3 adjusted EBITDA beat on benefits from savings while global volume points remained soft, the analyst tells investors in a research note.
Education
About Us
Working with TipRanks
Follow Us
1